CD73 Predicts Favorable Prognosis in Patients with Nonmuscle-Invasive Urothelial Bladder Cancer

Aims. CD73 is a membrane associated 5′-ectonucleotidase that has been proposed as prognostic biomarker in various solid tumors. The aim of this study is to evaluate CD73 expression in a cohort of patients with primary bladder cancer in regard to its association with clinicopathological features and...

Full description

Bibliographic Details
Main Authors: Marian S. Wettstein, Lorenz Buser, Thomas Hermanns, Filip Roudnicky, Daniel Eberli, Philipp Baumeister, Tullio Sulser, Peter Wild, Cédric Poyet
Format: Article
Language:English
Published: Hindawi Limited 2015-01-01
Series:Disease Markers
Online Access:http://dx.doi.org/10.1155/2015/785461